[SEROTONIN AND PSYCHIATRY].
D001714:Bipolar Disorder; D002395:Catecholamines; D004358:Drug Therapy; D006212:Hallucinations; D006213:Hallucinogens; D006801:Humans; D006897:Hydroxyindoleacetic Acid; D007004:Hypoglycemic Agents; D007210:Indoleacetic Acids; D008238:Lysergic Acid Diethylamide; D008635:Mescaline; D008660:Metabolism; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D011562:Psilocybin; D011570:Psychiatry; D011618:Psychotic Disorders; D012106:Research; D012559:Schizophrenia; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors
D002395:Catecholamines; D006213:Hallucinogens; D006897:Hydroxyindoleacetic Acid; D007004:Hypoglycemic Agents; D007210:Indoleacetic Acids; D008238:Lysergic Acid Diethylamide; D008635:Mescaline; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D011562:Psilocybin; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; C030737:indoleacetic acid; C031637:phenothiazine
ANTIDIABETICS; CATECHOLAMINES; DRUG THERAPY; EXPERIMENTAL LAB STUDY; HALLUCINATIONS; HALLUCINOGENS; HYDROXYINDOLEACETIC ACID; INDOLEACETIC ACID; LYSERGIC ACID DIETHYLAMIDE; MESCALINE; METABOLISM; MONOAMINE OXIDASE INHIBITORS; PHENOTHIAZINES; PSILOCYBINE; PSYCHOSES; PSYCHOSES, MANIC-DEPRESSIVE; SCHIZOPHRENIA; SEROTONIN; SEROTONIN INHIBITORS
S'EROTONINE ET PSYCHIATRIE.